Company: ZCARW
Filing Date: 2025-03-28
Form Type: DRS
Source: 0001013762-25-003498
Chunk: 100

Company: Zoomcar Holdings, Inc.
Filing Date: 2025-03-28
Form: DRS
Chunk 100
---
 been subject to securities litigation, including class action litigation. Litigation of this type could
result in substantial costs and diversion of management’s attention and resources, which could have a material adverse effect on
our business, financial condition, and results of operations. Any adverse determination in litigation could also subject us to significant
liabilities.

Risks Related to this Offering and Ownership of Our Common Stock

We have broad discretion in the use of the net proceeds from this offering and may not use them effectively.

Our management will have
broad discretion in the application of the net proceeds, including for any of the purposes described in the section of this prospectus
entitled “Use of Proceeds.” You will be relying on the judgment of our management with regard to the use of these net
proceeds, and you will not have the opportunity, as part of your investment decision, to assess whether the net proceeds are being used
appropriately. The failure by our management to apply these funds effectively could result in financial losses that could have a material
adverse effect on our business, cause the price of our securities to decline and delay the development of our product candidates. Pending
the application of these funds, we may invest the net proceeds from this offering in a manner that does not produce income or that loses
value.

<div align='center'>51</div>

The public offering price will be set by our Board and does not necessarily indicate the actual or market value of our common shares.

Our Board, or a committee
designated by the Board, will approve the public offering price and other terms of this offering after considering, among other things:
the current market price of our common shares; trading prices of our common shares over time; the volatility of our common shares; our
current financial condition and the prospects for our future cash flows; the availability of and likely cost of capital of other potential
sources of capital; the characteristics of interested investors and market and economic conditions at the time of the offering. The public
offering price is not intended to bear any relationship to the book value of our assets or our past operations, cash flows, losses, financial
condition, net worth or any other established criteria used to value securities. The public offering price may not be indicative of the
fair value of the common shares.

We will likely not receive any additional funds upon the exercise of the Series A Warrants.

The Series A Warrants may
be exercised by way of an alternate cashless exercise during the period of 90 calendar days following